Search - tctmd.com

Displaying 121 - 140 of 221

Sort: Relevancy | Date

News Daily News

US Athlete’s Death Highlights Risk of Hypertensive Disorders of Pregnancy

Michael O'Riordan

June 19, 2023

News Daily News

Testosterone Doesn’t Cause CV Events in High-Risk Men With Hypogonadism

Caitlin E. Cox

June 16, 2023

News Daily News

Obicetrapib Effective When Added to Statins and Ezetimibe: ROSE2

Michael O'Riordan

June 14, 2023

News Conference News TVT 2023

Prior TAVI Patients Needing Non-Aortic Valve Surgery Face Poor Outcomes

Michael O'Riordan

June 13, 2023

News Conference News TVT 2023

No-Implant Shunt for HF Looks Safe, Feasible in Early Snapshot

Michael O'Riordan

June 12, 2023

News Conference News TVT 2023

‘Excellent’ Outcomes With Mitral ViV Procedures, Even in Lower-Risk Patients

Michael O'Riordan

June 09, 2023

News Conference News LINC 2023

Early Data on Temporary Spur in BTK PAD Show Efficacy, Limited Recoil

L.A. McKeown

June 09, 2023

News Conference News TVT 2023

Solid Anchoring, Good Echo Results With Transapical TMVR at 2 Years

Michael O'Riordan

June 09, 2023

Presentation TVT 2023

“Patient-Specific Predictive Simulation of Transcatheter Edge-To-Edge Repair in Humans with Mitral Regurgitation”

Presenter: Michael Sacks

June 09, 2023

Presentation TVT 2023

Case Resolution: Management of Advanced HF in a Patient with Severe Secondary MR

Presenter: Michael Brener

June 08, 2023

Presentation TVT 2023

POINT: Try a MitraClip First!

Presenter: Michael Brener

June 08, 2023

Presentation TVT 2023

Case Presentation: Management of Advanced HF in a Patient with Severe Secondary MR

Presenter: Michael Brener

June 08, 2023

Presentation TVT 2023

Putting “Lifetime” Into Perspective (How Long Do Patients With AS / AVR Actually Survive)

Presenter: Michael Mack

June 08, 2023

News Daily News

CABG and PCI Comparable in ACS Patients With Left Main CAD

Michael O'Riordan

June 06, 2023

News Conference News HRS 2023

Serious Risks With ‘Jailing’ Pacemaker, ICD Leads During TTVR

Michael O'Riordan

June 05, 2023

News Conference News EAS 2023

With New LDL Goalposts in FH, Combo Therapy Must Start Early

Michael O'Riordan

May 29, 2023

News Conference News EAS 2023

Multipronged Outreach to Families Can Boost FH Cascade Screening: IMPACT-FH

Michael O'Riordan

May 26, 2023

News Conference News EAS 2023

Newest Resorbable Magnesium Scaffold Shows Promise in BIOMAG-1

Michael O'Riordan

May 25, 2023

News Conference News EAS 2023

Variable Response to Novel PCSK9 Inhibitor Lerodalcibep in LIBERATE-HoFH

Michael O'Riordan

May 24, 2023

News Conference News EAS 2023

High LDL, Poor Treatment, Early Death: HoFH Registry Paints Grim Picture

Michael O'Riordan

May 23, 2023

Advertisement

US Athlete’s Death Highlights Risk of Hypertensive Disorders of Pregnancy

Testosterone Doesn’t Cause CV Events in High-Risk Men With Hypogonadism

Obicetrapib Effective When Added to Statins and Ezetimibe: ROSE2

Prior TAVI Patients Needing Non-Aortic Valve Surgery Face Poor Outcomes

No-Implant Shunt for HF Looks Safe, Feasible in Early Snapshot

‘Excellent’ Outcomes With Mitral ViV Procedures, Even in Lower-Risk Patients

Early Data on Temporary Spur in BTK PAD Show Efficacy, Limited Recoil

Solid Anchoring, Good Echo Results With Transapical TMVR at 2 Years

“Patient-Specific Predictive Simulation of Transcatheter Edge-To-Edge Repair in Humans with Mitral Regurgitation”

Case Resolution: Management of Advanced HF in a Patient with Severe Secondary MR

POINT: Try a MitraClip First!

Case Presentation: Management of Advanced HF in a Patient with Severe Secondary MR

Putting “Lifetime” Into Perspective (How Long Do Patients With AS / AVR Actually Survive)

CABG and PCI Comparable in ACS Patients With Left Main CAD

Serious Risks With ‘Jailing’ Pacemaker, ICD Leads During TTVR

With New LDL Goalposts in FH, Combo Therapy Must Start Early

Multipronged Outreach to Families Can Boost FH Cascade Screening: IMPACT-FH

Newest Resorbable Magnesium Scaffold Shows Promise in BIOMAG-1

Variable Response to Novel PCSK9 Inhibitor Lerodalcibep in LIBERATE-HoFH

High LDL, Poor Treatment, Early Death: HoFH Registry Paints Grim Picture

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content